Anand Jha, Managing Director of ANSEA, took center stage at the ACCESS24 Europe Conference held in Barcelona, Spain, from November 14-16, 2024. This premier event brought together industry pioneers, thought leaders, and innovators to tackle the most pressing challenges in global healthcare access, pricing, and reimbursement.
Anand joined an esteemed panel in the Global Access & Funding for Medical Innovation session alongside Lou Garrison, Mikkel Z. Oestergaard, and Ansgar Hebborn. Together, they delved into critical topics, sparking thought-provoking discussions on:
- Differential Pricing Models: Unpacking how regional pricing strategies shape access to life-saving medicines.
- Drug Access Lag in Europe: Exploring innovative solutions to close the gap in timely access to treatments.
- Alternative Funding Models: Highlighting lessons from the hepatitis C treatment case study in the APAC region.
The session went beyond theory, exploring actionable strategies to address real-world issues. From redefining funding mechanisms to ensuring affordability based on economic diversity, the dialogue emphasized bridging the gap for underserved populations worldwide.
Hi Driving Impact on a Global Stage
Anand’s presence at the ACCESS24 Europe Conference underscored ANSEA’s unwavering commitment to reshaping healthcare access. By addressing complex challenges and proposing forward-thinking solutions, he reinforced ANSEA’s position as a leader in driving equitable access to medical innovations.
The conference, organized by the ACCESS Forum, provided a collaborative platform for healthcare leaders and innovators to share transformative ideas and build impactful partnerships.
Anand’s contributions resonated with the audience and reflected ANSEA’s mission to make healthcare innovation accessible to all, regardless of geographic or economic barriers.
